1 month AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat
Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the sto…
X